relapsed-refractory-multiple-myelomapatient.com domain details, SARCLISA® (isatuximab-irfc) | A Targeted Immunotherapy

home > domains > relapsed-refractory-multiple-myelomapatient.com

domain urls (10) domain links in (0) domain links out (5)

Description: SARCLISA is a targeted monoclonal antibody given with other medicines for adults with previously treated multiple myeloma. See Full Safety & Prescribing Info.

Domain rank: 100000000

Domain speed: Average (0.267 seconds at 0.431 MB/s)

Indexed URLs from relapsed-refractory-multiple-myelomapatient.com website (10)

The links in column here only counts links from external domains.

found date
links in
url title
url
2023-01-07
0
SARCLISA® (isatuximab-irfc) | Frequently Asked Questions
relapsed-refractory-multiple-myelomapatient.com/frequently-asked-questions.html
2023-01-07
0
SARCLISA® (isatuximab-irfc) | A Targeted Immunotherapy
relapsed-refractory-multiple-myelomapatient.com/get-the-latest.html
2023-01-07
0
SARCLISA® (isatuximab-irfc) | How SARCLISA Works
relapsed-refractory-multiple-myelomapatient.com/how-sarclisa-works.html
2023-01-07
0
SARCLISA® (isatuximab-irfc) | About Previously Treated Multiple Myeloma
relapsed-refractory-multiple-myelomapatient.com/when-multiple-myeloma-returns.html
2023-01-07
0
relapsed-refractory-multiple-myelomapatient.com/possible-side-effects.html
2023-01-07
0
SARCLISA® (isatuximab-irfc) | See the Clinical Study Results
relapsed-refractory-multiple-myelomapatient.com/clinical-study-results.html
2023-01-07
0
SARCLISA® (isatuximab-irfc) | Treatment With SARCLISA
relapsed-refractory-multiple-myelomapatient.com/receiving-sarclisa.html
2022-07-10
0
SARCLISA® (isatuximab-irfc) | A Targeted Immunotherapy
relapsed-refractory-multiple-myelomapatient.com
2023-01-07
0
SARCLISA® (isatuximab-irfc) | Patient & Caregiver Resources
relapsed-refractory-multiple-myelomapatient.com/resources.html
2023-01-07
0
relapsed-refractory-multiple-myelomapatient.com/paying-for-sarclisa.html

Plain text list